Verona Stock Soars After $200m Placement For COPD Drug

Fundraise Nearly Quadruples Market Cap

 
• By Kevin Grogan
  
Leaves_Lungs
Verona could bring the first new class of COPD drugs in decades to market • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business